Literature DB >> 18316508

Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature.

N U Haliloglu1, Z Yesilirmak, A Erden, I Erden.   

Abstract

Rhino-orbito-cerebral mucormycosis (ROCM) is a rare, fulminant opportunistic fungal infection that is mostly seen in immunocompromised or diabetic patients. The disease should be recognised and treated immediately. We present here MR imaging findings of two patients with histopathologically proven ROCM. One of the cases had a history of corticosteroid treatment and iatrogenic diabetes mellitus and although amphotericin B was started immediately, the disease progressed and surgical debridement was necessary. The second case was a patient with diabetes mellitus type 1 in whom ROCM had occurred following an abdominal surgery; amphotericin B treatment alone was adequate in this patient.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316508     DOI: 10.1259/dmfr/14698002

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  5 in total

1.  Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.

Authors:  Dong Ming Li; Li De Lun
Journal:  Front Med (Lausanne)       Date:  2022-06-17

2.  Rhino-orbital mucourmycosis in a non-immunocompromised patient.

Authors:  Asifur Rahman; Khaleda Akter; Shakhawat Hossain; Harun Ur Rashid
Journal:  BMJ Case Rep       Date:  2013-02-06

3.  Rhinomaxillary mucormycosis: A palatal ulcer.

Authors:  Ranjana Garg; Vivek Vijay Gupta; L Ashok
Journal:  Contemp Clin Dent       Date:  2011-04

4.  Rhinocerebrocutaneous mucormycosis caused by Mucor species: A rare causation.

Authors:  Snehal Balvant Lunge; Vijaya Sajjan; Ashok M Pandit; Vaibhav B Patil
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

5.  Mucormycosis in pre-COVID-19 and COVID-19 era: A study of prevalence, risk factors and clinical features.

Authors:  Parisa Arjmand; Milad Bahrami; Zahra Eslami Mohammadie; Mohammadhossein Taherynejad; Negar Yeganeh Khorasani; Hassan Mehrad-Majd; Imaneh Roshanzamir; Mehdi Bakhshaee
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.